Clrb stock price target
Cellectar Biosciences (NASDAQ:CLRB) ‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Tuesday, AnalystRatings.com reports. They currently have a $3.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 51.52% from the stock’s previous close. Analysts Offer Insights on Healthcare Companies: Zynerba ... Cellectar Biosciences (CLRB) In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Cellectar Biosciences, with a price target of $3.00. The company’s shares closed last Monday at $2.69. According to TipRanks.com, Ramakanth is a 1-star analyst with an average return of 0.0% and a 37.5% success rate CLRB | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CELLECTAR BIOSCIENCES INC (CLRB), including profile, stock chart, recent news and events, analyst opinions, and research reports. Cellectar Biosciences (CLRB) Stock: Buy Reiterated At ...
CLRB Stock | CELLECTAR BIOSCIENCES Stock Price Today ...
See Continental Resources price target based on 18 analysts offering 12 month price targets for Continental Resources in the last 3 months. The average price target is $13.87 with a high forecast of $42.00 and a low forecast of $3.00. The average price target represents a 66.31% increase from the last price of $8.34. CLRB Stock | CELLECTAR BIOSCIENCES Stock Price Today ... CLRB: Get the latest Cellectar Biosciences stock price and detailed information including CLRB news, historical charts and realtime prices. Cellectar Biosciences Inc : CLRB Stock Price Quote at Ally ... Free current stock price quotes and data for Cellectar Biosciences Inc (CLRB). Research news, charts, stock market performance and earnings. Quotes Snapshot > CLRB. Cellectar Biosciences Inc CLRB:NASDAQ. Set Alert Options Streaming Charts. Last Roth Capital Starts Cellectar Biosciences at Buy With $11 Price Target 9:56AM ET 9/13/2019 MT CLBS Caladrius Biosciences, Inc. — Stock Price and ... Apr 03, 2020 · Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. …
Nov 06, 2019 · Cellectar Biosciences Inc. analyst estimates by MarketWatch. View CLRB revenue estimates and earnings estimates, as well as analyst recommendations.
CLRB Stock Price | Cellectar Biosciences Inc. Stock Quote ...
Cellectar Biosciences, Inc. (CLRB) Latest Stock News ...
Get breaking news and analysis on Cellectar Biosciences, Inc. (CLRB) stock, price quote and chart, trading and investing tools. Cellectar Biosciences Inc. (CLRB) Stock Message Board ... Mar 16, 2020 · Our proprietary phospholipid ether (PLE) platform technology features include the capacity to link to a wide variety of warheads, provide a significant increase in targeted oncologic warhead delivery and the ability to target all tumor cells. CLRB - Cellectar Biosciences Inc Stock quote - CNNMoney.com Find real-time CLRB - Cellectar Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. CLRB - Cellectar Biosciences Inc Stock quote - CNNMoney.com Markets
Based on 3 analysts offering 12 month price targets for Cellectar Biosciences in the last 3 months. The average price target is $6.33 with a high forecast of
Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update. FLORHAM PARK, N.J., March 09, 2020 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and.
CLRB: Get the latest Cellectar Biosciences stock price and detailed information including CLRB news, historical charts and realtime prices.